Helicobacter pylori heteroresistance to clarithromycin in adults—New data by in situ detection and improved concept
Adult
Male
0303 health sciences
Helicobacter pylori
Biopsy
Gastroenterology
General Medicine
Middle Aged
Anti-Bacterial Agents
Helicobacter Infections
3. Good health
clarithromycin resistance; FISH; Helicobacter pylori; heteroresistance; in situ hybridization
03 medical and health sciences
Infectious Diseases
Clarithromycin
Drug Resistance, Bacterial
Humans
Female
In Situ Hybridization, Fluorescence
Aged
DOI:
10.1111/hel.12670
Publication Date:
2019-11-08T09:56:07Z
AUTHORS (12)
ABSTRACT
Abstract Background Clarithromycin (Cla) heteroresistance of Helicobacter pylori ( H ) infections is commonly assessed by comparing the resistance status antrum and corpus biopsy samples demonstrating discrepancy between them (interniche heteroresistance). However, fluorescence in situ hybridization (FISH) technique capable showing synchronous presence susceptible resistant bacteria (intraniche heteroresistance), enabling detection heteroresistant populations within one sample. Materials Methods Antrum specimens 305 ‐infected patients were investigated with an rRNA‐targeted Cla‐resistance FISH test. Anamnestic data collected from institutional electronic register. Prevalence rates susceptible, homo‐ cases correlated anamnestic clinicopathological data. Results Overall rate was 23.9% (73 cases), consisting 35 (11.5%) homoresistant 38 (12.5%) cases. Thirty‐five had at least site where present simultaneously. From this subset, 20 demonstrated intraniche on both sites. Prior Cla‐based eradication attempts more frequent than P < .001, respectively). Cla‐containing therapy eradicated a significantly lower comparison = .0112), but effectively homoresistants .0393). Conclusions The most type Cla‐heteroresistance coexistence same location A previous attempt predisposes to infection. Heteroresistance characterized non‐eradication‐related background intermediate characteristics many respects when compared
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (44)
CITATIONS (24)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....